David Saltzman

Ropes & Gray - UNITED STATES


David Saltzman's competencies

Practice AreaJurisdictionRankAgg. Deals ValueClients DimensionN. of TransactionsLast Quarter
Tax CorporateUNITED STATES125501501
Tax FinanceUNITED STATES196150050001
Tax M&A and Deal AdvisoryUNITED STATES2044720325212
Practice AreaJurisdictionRankAgg. Deals ValueClients DimensionN. of TransactionsLast Quarter
Showing 1 to 3 of 3 entries

Client Reviews

The Client Reviews provides a qualitative rating based on Partners' Clients feedback assessment


Communication Skills

0255075100Below expectationMeet expectationExceed expectation0

Technical skills

0255075100Below expectationMeet expectationExceed expectation0

Efficiency

0255075100Below expectationMeet expectationExceed expectation0


Effectiveness

0255075100Below expectationMeet expectationExceed expectation0



Perceived Added Value

0255075100

Ranking 2022: David Saltzman - Ropes & Gray

Practice AreaAgg. Deals ValueClients DimensionN. of TransactionsTier
Tax Corporate5501501
Tax Finance150050001
Tax M&A and Deal Advisory44720325212
Practice AreaAgg. Deals ValueClients DimensionN. of TransactionsTier
Showing 1 to 3 of 3 entries

Ranking 2021: David Saltzman - Ropes & Gray

Practice Area Agg. Deals Value Clients Dimension N. of Transactions Tier
Tax M&A and Deal Advisory6580196310
Practice Area Agg. Deals Value Clients Dimension N. of Transactions Tier

Ranking 2020: David Saltzman - Ropes & Gray

Practice Area Agg. Deals Value Clients Dimension N. of Transactions Tier
Tax M&A and Deal Advisory66015705
Practice Area Agg. Deals Value Clients Dimension N. of Transactions Tier

Significant Clients

The chart shows a balanced list of the David H. Saltzman's client portfolio - based on PBV Monitor's Analyzed Transactions during last Twelve Mounths
Planet Fitness, Inc.Morgan Stanley & Co. LLCTD Securities USASarepta Therapeutics, Inc.Robert W. Baird & Co.RBC Capital MarketsPiper SandlerNona BiosciencesMoelis & CompanyLepu Biopharma Co., Ltd.Kailera TherapeuticsJefferiesJ.P. Morgan Securities LLCGilgamesh PharmaceuticalsGauge Capital, LLCG1 Therapeutics, Inc.Cosette PharmaceuticalsCitigroup Global MarketsInc.Chiesi FarmaceuticiCantor FitzgeraldBRP GroupBain CapitalApollo Therapeutics05K10KRevenue (ML. Euro)

Team

The chart shows a balanced list of counselor working with David H. Saltzman - based on PBV Monitor's analyzed transactions during last Twelve Mounths
Lisa KaltenbrunnerKellie CombsWilliam MichenerThomas FraserRenata FerrariRaymond GrantPeter AlpertNicole RohrMichael McFallsMargaux HallKelly FinnJimmy ChenHannah EnglandDeidre JohnsonAdamGreenwoodAbigail GregorZhen ZhangTristanVanDeventerTara FisherSarah YoungSara CleveringSam LevittRyan KramerRaxit ShahRajarshiBanerjeeRachel PhillipsPeter WelshPeter ChiPaul ArmstrongPatricia LynchPascal MayerMelissa RonesMegan BiskMatthieuWharmbyMatthewRichardsMatt JonesMarcRubensteinLindsey JonesLincoln TsangLaura HoeyKatherine WangJoshua OysterJordan AltmanJonathanKlarfeldJeremy LiaboJane WillisJacqueline GriseJackie CohenIsabel DischeIan A. NilsenGregory BauerGeoffrey LinFran FairclothEvan TallmadgeErica HanDerek MubiruDeborah GershDayna AtkinsDavid KayeDavid BlittnerDaniel FormanCraig MarcusChristopherComeauChristopherAgnoliBrendanHanifinBenjaminRogersArthur MokArek MaczkaAndrew DevoreAnaGomez-PalazzoAmandaWhiteAmanda HoltAmanda AustinAmaAdams08.25K16.5KAgg. deal value (ML. Euro)

Co-Counsel

The Chart shows a balanced list of David H. Saltzman's Co-Counsel Law Firm - based on PBV Monitor's analyzed transactions during last Twelve Mounths
Stikeman ElliottCorrs Chambers Westgarth0225450Agg. deal value (ML. Euro)

Counterparts

The Chart shows a balanced list of David H. Saltzman's other Firms involved - based on PBV Monitor's analyzed transactions during last Twelve Mounths
Meister Seelig & Fein LLPFasken Martineau DuMoulin LLPMcCarthy TétraultBrown Rudnick LLPSkaddenLatham & WatkinsSimpson Thacher & BartlettArnold & PorterGibson Dunn & CrutcherBenesch Friedlander Coplan & Aronoff07.5K15KAgg. deal value (ML. Euro)

Peer Reviews

The Peer Reviews provides a qualitative rating based on Counterparts / Referees' feedback assessment


0%20%40%60%80%100%Communication SkillsTechnical skillsEfficiencyEffectivenessPerceived Added Value

Recent experiences

Cosette Pharmaceuticals' $430 Million Acquisition of Mayne Pharma Group2/24/2025
Lepu Biopharma's $1.6 Billion ADC Licensing Agreement with ArriVent Biopharma1/27/2025
Arrowhead Pharmaceuticals' Lincense Collaboration Agreement with Sarepta Therapeutics11/29/2024
Apollo Therapeutics' Exclusive License Agreement with Sunshine Lake Pharma11/14/2024
Kailera Therapeutics' $400 Million Series A Financing10/22/2024
Gauge Capital's Investment in AGT Robotics9/3/2024